dihydroxyphenylalanine has been researched along with Asperger Syndrome in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Asperger Syndrome: A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The etiology of Asperger syndrome is essentially unknown, but abnormality of the dopamine system has been shown in clinically overlapping disorders." | 1.32 | Increased presynaptic dopamine function in Asperger syndrome. ( Aalto, S; Autti, TH; Bergman, J; Eskola, O; Hietala, JA; Kulomäki, TA; Metsähonkala, L; Nieminen-von Wendt, TS; Vanhala, R; von Wendt, LO, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nieminen-von Wendt, TS | 1 |
| Metsähonkala, L | 1 |
| Kulomäki, TA | 1 |
| Aalto, S | 1 |
| Autti, TH | 1 |
| Vanhala, R | 1 |
| Eskola, O | 1 |
| Bergman, J | 1 |
| Hietala, JA | 1 |
| von Wendt, LO | 1 |
1 other study available for dihydroxyphenylalanine and Asperger Syndrome
| Article | Year |
|---|---|
Increased presynaptic dopamine function in Asperger syndrome.
Topics: Adult; Asperger Syndrome; Basal Ganglia; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; F | 2004 |